AzurRx BioPharma, Inc.
NASDAQ: AZRX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- James Sapirstein
- Employees
- 12
- Headquarters
- Brooklyn, United States
- IPO year
- 2016
- Market cap
- $3.4M
- Website
- http://www.azurrx.com
Loading AZRX…
Loading profile data…Frequently asked questions about AZRX
What does AzurRx BioPharma, Inc. (AZRX) do?
AzurRx BioPharma, Inc., a Brooklyn, New York-based company employing 12 full-time individuals, focuses on the discovery and advancement of non-systemic biological treatments for various gastrointestinal conditions. Its current developmental portfolio comprises two therapeutic protein assets: MS1819 and AZX1101. MS1819 is an acid-stable lipase en...
Where does AZRX trade?
AzurRx BioPharma, Inc. (AZRX) trades on the NASDAQ Capital Market.
What sector is AZRX in?
AzurRx BioPharma, Inc. (AZRX) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of AzurRx BioPharma, Inc.?
James Sapirstein is the chief executive officer of AzurRx BioPharma, Inc. (AZRX).
Where is AzurRx BioPharma, Inc. headquartered?
AzurRx BioPharma, Inc. is headquartered in United States.
Does AZRX pay a dividend?
AzurRx BioPharma, Inc. (AZRX) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did AZRX go public?
AzurRx BioPharma, Inc. (AZRX) completed its initial public offering in 2016.